REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.54
Bid: 1.536
Ask: 1.54
Change: 0.046 (3.08%)
Spread: 0.004 (0.26%)
Open: 1.52
High: 1.54
Low: 1.482
Prev. Close: 1.494
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB 3rd Quarter Consolidated Condensed Results

16 Dec 2020 07:00

RNS Number : 7812I
Commercial Intnl Bank (Egypt) SAE
16 December 2020
 

 

.Commercial International Bank (Egypt) S.A.E 

Consolidated Condensed Financial Statements 

September 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Balance Sheet as at September 30, 2020

 

 

Notes

Sep. 30, 2020

 

Dec. 31, 2019

 

 

EGP Thousands

 

EGP Thousands

 

Assets

 

 

 

 

 

Cash and balances at the central bank

7

35,786,423

 

28,273,962

 

Due from banks

8

56,903,819

 

28,353,366

 

Loans and advances to banks, net

10

19,021

 

625,264

 

Loans and advances to customers, net

11

119,145,984

 

119,321,103

 

Derivative financial instruments

 

242,694

 

216,383

 

Investments

 

 

 

 

 

- Financial Assets at Fair value through P&L

12

344,219

 

418,781

 

- Financial Assets at Fair value through OCI

12

119,938,583

 

89,897,257

 

- Amortized cost

12

69,896,376

 

107,225,613

 

- Investments in associates

13

141,772

 

107,693

 

Other assets

 

9,398,676

 

9,748,143

 

Goodwill

0

223,328

 

-

 

Deferred tax assets (Liabilities)

 

413,720

 

350,339

 

Property, plant and equipment

14

2,265,502

 

2,204,464

 

Total assets

 

414,720,117

 

386,742,368

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

15

8,820,095

 

11,810,607

 

Due to customers

16

332,326,819

 

304,448,455

 

Derivative financial instruments

 

305,164

 

282,588

 

Current tax liabilities

 

1,359,201

 

4,639,364

 

Other liabilities

 

6,656,244

 

8,396,794

 

Other loans

 

7,764,995

 

3,272,746

 

Provisions

17

2,960,720

 

2,011,369

 

Total liabilities

 

360,193,238

 

334,861,923

 

Equity

 

 

 

 

 

Issued and paid up capital

 

14,776,813

 

14,690,821

 

Reserves

 

30,496,156

 

24,344,815

 

Reserve for employee stock ownership plan (ESOP)

 

1,410,846

 

963,152

 

Retained earnings *

 

7,501,210

 

11,881,657

 

Total equity

 

54,185,025

 

51,880,445

 

Minority interest

 

341,854

 

-

 

Total minority interest, equity and net profit for the period/year

54,526,879

 

51,880,445

 

Total liabilities and equity

 

414,720,117

 

386,742,368

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements .

 

 

 

 

 

(Review report attached)

 

 

 

 

*

Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Board member

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of other Comprehensive Income for the period ended September 30, 2020

 

 

 

Last 9 Months

 

Last 9 Months

 

 

 

 

 

 

Sep. 30, 2020

 

Sep. 30, 2019

 

 

 

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

 

Net profit for the period

 

 

7,344,292

 

8,537,594

 

 

 

 

 

 

 

 

 

 

 

 

Net change in fair value of instruments measured at fair value through other comprehensive income

 

 

(2,292,039)

 

5,271,372

 

 

 

Transferred from reserve for financial assets at fair value through OCI

 

 

(76,717)

 

-

 

 

 

Cumulative foreign currencies translation differences

 

 

1,314

 

3,747

 

 

 

Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income

 

 

88,192

 

(71,846)

 

 

 

Total other comprehensive income for the period

 

 

5,065,042

 

13,740,867

 

 

 

 

 

 

 

 

 

 

 

 

As follows:

 

 

 

 

 

 

 

 

Bank's shareholders

 

 

5,067,142

 

13,740,867

 

 

 

Minority interest

 

 

(2,100)

 

-

 

 

 

Total other comprehensive income for the period

 

 

5,065,042

 

13,740,867

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended September 30, 2020

 

 

 

 

 

 

Notes

Sep. 30, 2020

 

Sep. 30, 2019

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax from continued operations

 

11,239,451

 

11,773,726

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

14

558,536

 

425,637

Impairment charge for credit losses (Loans and advances to customers and banks)

 

3,761,456

 

1,256,000

Other provisions charges

17

974,522

 

12,494

Impairment charge for credit losses (due from banks)

 

13,218

 

23,161

Impairment charge for credit losses (financial investments)

 

88,192

 

(71,846)

Impairment charge for other assets

 

56,245

 

83,213

Exchange revaluation differences for financial assets at fair value through OCI

 

238,906

 

1,303,741

Goodwill amortization

22

20,302

 

-

Intangible assets amortization

 

-

 

97,656

Impairment charge financial assets at fair value through OCI

 

79,126

 

45,664

Utilization of other provisions

17

(1,479)

 

(27,733)

Other provisions no longer used

17

(6,022)

 

(96,499)

Exchange differences of other provisions

17

(17,670)

 

(103,531)

Profits from selling property, plant and equipment

 

(872)

 

(1,439)

(Profits) losses from selling financial investments

12

(979,144)

 

(310,329)

Released (Impairment) charges of investments in associates and subsidiaries

 

14,100

 

-

Shares based payments

 

447,694

 

371,997

Bank's share in the profits of associates

 

(24,327)

 

(291)

Operating profits before changes in operating assets and liabilities

 

16,462,234

 

14,781,621

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

 

(5,972,551)

 

(13,052,086)

Treasury bills and other governmental notes

 

(4,492,317)

 

4,974,205

Financial assets at fair value through P&L

12

74,562

 

2,252,280

Derivative financial instruments

 

(3,735)

 

(67,282)

Loans and advances to banks and customers

10 - 11

(2,977,814)

 

(4,796,325)

Other assets

 

592,680

 

247,459

Due to banks

15

(2,990,512)

 

(5,431,711)

Due to customers

16

27,878,364

 

22,548,279

Income tax obligations paid

 

(4,389,254)

 

(3,625,579)

Other liabilities

 

(4,589,999)

 

1,862,821

Net cash used in (generated from) operating activities

 

19,591,658

 

19,693,682

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from Investments in associates.

 

750

 

-

Payment for purchases of property, plant, equipment and branches constructions

 

(921,312)

 

(1,067,918)

Proceeds from selling property, plant and equipment

 

872

 

1,439

Proceeds from redemption of financial assets at amortized cost

 

37,493,345

 

33,937,957

Payment for purchases of financial assets at amortized cost

 

-

 

(47,344,534)

Payment for purchases of financial assets at fair value through OCI

 

(51,331,273)

 

(26,637,577)

Proceeds from selling financial assets at fair value through OCI

 

24,041,845

 

5,350,754

Proceeds from investment in subsidiaries.

 

194,722

 

-

Net cash generated from (used in) investing activities

 

9,478,949

 

(35,759,879)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Increase (decrease) in long term loans

 

4,492,249

 

(321,235)

Dividend paid

 

(3,370,464)

 

(2,700,544)

Capital increase

 

85,992

 

-

Net cash generated from (used in) financing activities

 

1,207,777

 

(3,021,779)

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the period

 

30,278,384

 

(19,083,872)

Beginning balance of cash and cash equivalent

 

22,895,017

 

34,303,645

Cash and cash equivalent at the end of the period

 

53,173,401

 

15,219,773

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

7

35,786,423

 

27,205,020

Due from banks

 

56,934,238

 

25,629,602

Treasury bills and other governmental notes

9

32,133,958

 

44,736,504

Obligatory reserve balance with CBE

7

(30,004,955)

 

(20,770,245)

Due from banks with maturities more than three months

 

(8,958,909)

 

(16,541,989)

Treasury bills with maturity more than three months

 

(32,717,354)

 

(45,039,119)

Total cash and cash equivalent

 

53,173,401

 

15,219,773

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended September 30, 2019

 

 

 

Sep. 30, 2019

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

 

Beginning balance

11,668,326

1,710,293

12,776,215

1,549,445

12,421

(1,860,851)

4,323

9,637,083

738,320

-

36,235,575

-

36,235,575

 

 

Capital increase

2,917,082

-

(2,917,082)

-

-

-

-

-

-

-

-

-

-

 

 

Transferred to reserves

-

477,736

6,375,589

-

1,045

-

-

(6,854,370)

-

-

-

-

-

 

 

Dividend paid

-

-

-

-

-

-

-

(2,700,544)

-

-

(2,700,544)

-

(2,700,544)

 

 

Net profit of the period

-

-

-

-

-

-

-

8,537,594

-

-

8,537,594

-

8,537,594

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

5,271,372

-

-

-

-

5,271,372

-

5,271,372

 

 

Transferred (from) to bank risk reserve

-

-

-

-

-

-

841

(841)

-

-

-

-

-

 

 

ECL for impairment of debt instruments investments

-

-

-

-

-

(71,846)

-

-

-

-

(71,846)

-

(71,846)

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

371,997

-

371,997

-

371,997

 

 

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

3,747

3,747

-

3,747

 

 

Balance at the end of the period

14,585,408

2,188,029

16,234,722

1,549,445

13,466

3,338,675

5,164

8,618,922

1,110,317

3,747

47,647,895

-

47,647,895

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended September 30, 2020

 

 

 

Sep. 30, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

 

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,881,657

963,152

2,501

51,880,445

-

51,880,445

 

 

Capital increase

85,992

-

-

-

-

-

-

-

-

-

85,992

-

85,992

 

 

Transferred to reserves

-

590,106

7,840,287

-

1,440

-

-

(8,431,833)

-

-

-

-

-

 

 

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

-

(3,370,464)

-

(3,370,464)

 

 

Minority Interest share

-

-

-

-

-

-

-

-

-

-

-

343,954

343,954

 

 

Net profit of the period

-

-

-

-

-

-

-

7,346,392

-

-

7,346,392

(2,100)

7,344,292

 

 

Transferred from reserve for financial assets at fair value through OCI

-

-

-

-

-

(76,717)

-

76,717

-

-

-

-

-

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(2,292,039)

-

-

-

-

(2,292,039)

-

(2,292,039)

 

 

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

-

-

-

 

 

Release provision for impairment of debt instruments investments

-

-

-

-

-

88,192

-

-

-

-

88,192

-

88,192

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

447,694

-

447,694

-

447,694

 

 

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

(1,187)

(1,187)

-

(1,187)

 

 

Balance at the end of the period

14,776,813

2,778,135

24,314,716

1,549,445

14,906

1,831,217

6,423

7,501,210

1,410,846

1,314

54,185,025

341,854

54,526,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/7812I_1-2020-12-16.pdf

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTBQLBFBLLXFBV
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.